PharmaJet Tropis is now the exclusive intradermal delivery system for two novel Covid-19 vaccines in India. It has been used for millions of injections in multiple immunization campaigns worldwide.

More information: Lara M. Mollé et al, Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery, WIREs Nanomedicine and Nanobiotechnology (2022).

Nucleic acid therapies offer targeted treatment for genetic diseases, but delivery remains a key hurdle. Explore how advances ...

The nucleic acid delivery market is maturing with over 1,450 clinical trials underway worldwide. The majority of these are in early clinical development (approximately 60%) with just over 3% in ...

Development of an Elastin-like Polypeptide-Based Nucleic Acid Delivery System Targeted to EGFR+ Bladder Cancer Cells Using a Layer-by-Layer Approach. Biomacromolecules, 2024; DOI: 10.1021/acs ...

Study: Nucleic acid delivery and nanoparticle design for COVID vaccines. Image Credit: Love Employee / Shutterstock.com Introduction Nucleic acid therapeutics can harness the potential of genetics ...

Researchers trace the 60-year evolution of lipid nanoparticles (LNPs) for nucleic acid delivery, highlighting their potential to revolutionize gene therapy with safer and more effective treatments.

Just a few short months after the biotech’s nucleic acid delivery tech helped land a deal with BioMarin, the Edmonton, Alberta-based Canadian company has teamed up with Eli Lilly for $50 million ...

Eli Lilly and Company has acquired exclusive rights to Entos Pharmaceuticals’ nucleic acid delivery technology for $50 million. As part of the deal, Entos will create proteolipid vehicles for ...

Purdue University researcher David Thompson has developed LENN, a system to deliver nucleic acid-based therapies to targeted cancer cells. His and his team’s research into using LENN to deliver ...